Poly-L-lactide acid-modified scaffolds for osteoinduction and osteoconduction

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Tissue Engineering

Background:

• Poly-L-lactide acid (PLLA) scaffolds are used in bone tissue engineering but require enhanced osteoconductive and osteoinductive properties.
• Current modifications include surface coatings and peptide grafting to improve cellular interactions and bone regeneration.

Purpose of the Study:

• To enhance the osteoconductive and osteoinductive properties of PLLA scaffolds for bone tissue engineering.
• To evaluate the efficacy of grafting with arginine-glycine-aspatic acid (RGD) peptides and incorporating 1,25-(OH)₂ D3.

Main Methods:

• PLLA scaffolds were modified by coating with laminin/fibronectin or grafting with RGD/SIKVAV peptides.
• Bioactive 1,25-(OH)₂ D3 was incorporated into the scaffolds.
• Cell adhesion, proliferation, osteogenic marker expression, and mineralization were assessed using human osteoblasts (hOB) and human mesenchymal stem cells (hMSCs).

Main Results:

• Grafted scaffolds (RGD-PLLA) supported enhanced proliferation of hOB and hMSCs compared to ungrafted PLLA.
• While RGD grafting promoted cell adhesion and proliferation, it did not significantly enhance osteogenic induction alone.
• 1,25-(OH)₂ D3 incorporation into RGD-PLLA scaffolds significantly increased cell proliferation, upregulated osteogenic markers, and induced hMSCs differentiation into osteoblasts.

Conclusions:

• RGD-PLLA scaffolds demonstrate potential for improved cell adhesion and proliferation in bone regeneration.
• The combination of RGD grafting and 1,25-(OH)₂ D3 incorporation (RGD-D3-PLLA) results in a highly effective osteogenic material.
• RGD-D3-PLLA scaffolds exhibit significant osteoconductivity and osteoinductivity, indicating promise for future bone replacement applications.